Fem-dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1 and RC-14 to colonize and protect the vaginal tract.
Clinical trials have shown that GR-1 and RC-14:
• Help to maintain or restore healthy vaginal flora that are important in maintaining vaginal health. • Support the health of the urinary tract.
Fem-dophilus is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency. The probiotic strains in fem-dophilus are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.
*Statements on this site have not been evaluated by the Food and Drug Administration.
Products on this site are not intended to diagnose, treat, cure, or prevent any disease.
Prices are subject to change at anytime and without notice.
The majority of the product information has been reprinted from the manufacturer.